Recombinant 2019-nCoV Guanine-N7_meth (N-6His)

Artikelnummer: EBT-EPT003
Artikelname: Recombinant 2019-nCoV Guanine-N7_meth (N-6His)
Artikelnummer: EBT-EPT003
Hersteller Artikelnummer: EPT003
Alternativnummer: EBT-EPT003-50
Hersteller: ELK Biotechnology
Kategorie: Proteine/Peptide
Alternative Synonym: SARS-CoV 2 nsp14, SARS-CoV 2 ExoN, Guanine-N7 methyltransferase
Recombinant 2019-nCoV Guanine-N7 methyltransferase is produced by our E.coli expression system and the target gene encoding Ala1-Gln527 is expressed with a 6His tag at the N-terminus.
Molekulargewicht: Molecular weight: 62.9 KDa. Apparent molecular weight: 60 KDa, reducing conditions
UniProt: YP_009725309.1
Reinheit: Greater than 85% as determined by reducing SDS-PAGE.
Anwendungsbeschreibung: Background: The nonstructural protein (nsp) 14 of SARS-CoV 2 was identified as a cap (guanine-N7)-methyltransferase (N7-MTase). Nsp14 of coronaviruses two different activities: an exoribonuclease activity acting on both ssRNA and dsRNA in a 3 to 5 direction and a N7-guanine methyltransferase activity. It may be involved in the proof-reading ability during the viral RNA replication and transcription. GTP, dGTP as well as cap analogs GpppG, GpppA and m7GpppG could be methylated by nsp14